The assisted reproductive technology laboratories and regulatory agencies

CLIA '88, CAP, and the Wyden Bill

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

At present, the practice of assisted reproductive technology (ART) in the United States is subject to only minimal voluntary standards guidelines. Controversy exists concerning who should be regulated how much regulation is needed what form this regulation should take. This controversy has centered around the very definition of a 'clinical laboratory' as it relates to ART the differences between the practice of medicine clinical laboratory testing. Regulation of the embryology laboratory component of ART is at present uncertain debatable confusing. This article will attempt to point out the various regulatory agencies requirements that impinge on the field of ART as they exist today discuss possible oversight mechanisms that may come into play in the near future.

Original languageEnglish (US)
Pages (from-to)311-330
Number of pages20
JournalInfertility and Reproductive Medicine Clinics of North America
Volume9
Issue number2
StatePublished - Jan 1 1998
Externally publishedYes

Fingerprint

Assisted Reproductive Techniques
Embryology
Clinical Medicine
Guidelines

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

@article{8628712e41774c6e92337011ad6efa7e,
title = "The assisted reproductive technology laboratories and regulatory agencies: CLIA '88, CAP, and the Wyden Bill",
abstract = "At present, the practice of assisted reproductive technology (ART) in the United States is subject to only minimal voluntary standards guidelines. Controversy exists concerning who should be regulated how much regulation is needed what form this regulation should take. This controversy has centered around the very definition of a 'clinical laboratory' as it relates to ART the differences between the practice of medicine clinical laboratory testing. Regulation of the embryology laboratory component of ART is at present uncertain debatable confusing. This article will attempt to point out the various regulatory agencies requirements that impinge on the field of ART as they exist today discuss possible oversight mechanisms that may come into play in the near future.",
author = "Keel, {Brooks Allen}",
year = "1998",
month = "1",
day = "1",
language = "English (US)",
volume = "9",
pages = "311--330",
journal = "Infertility and Reproductive Medicine Clinics of North America",
issn = "1047-9422",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - The assisted reproductive technology laboratories and regulatory agencies

T2 - CLIA '88, CAP, and the Wyden Bill

AU - Keel, Brooks Allen

PY - 1998/1/1

Y1 - 1998/1/1

N2 - At present, the practice of assisted reproductive technology (ART) in the United States is subject to only minimal voluntary standards guidelines. Controversy exists concerning who should be regulated how much regulation is needed what form this regulation should take. This controversy has centered around the very definition of a 'clinical laboratory' as it relates to ART the differences between the practice of medicine clinical laboratory testing. Regulation of the embryology laboratory component of ART is at present uncertain debatable confusing. This article will attempt to point out the various regulatory agencies requirements that impinge on the field of ART as they exist today discuss possible oversight mechanisms that may come into play in the near future.

AB - At present, the practice of assisted reproductive technology (ART) in the United States is subject to only minimal voluntary standards guidelines. Controversy exists concerning who should be regulated how much regulation is needed what form this regulation should take. This controversy has centered around the very definition of a 'clinical laboratory' as it relates to ART the differences between the practice of medicine clinical laboratory testing. Regulation of the embryology laboratory component of ART is at present uncertain debatable confusing. This article will attempt to point out the various regulatory agencies requirements that impinge on the field of ART as they exist today discuss possible oversight mechanisms that may come into play in the near future.

UR - http://www.scopus.com/inward/record.url?scp=0031863510&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031863510&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 311

EP - 330

JO - Infertility and Reproductive Medicine Clinics of North America

JF - Infertility and Reproductive Medicine Clinics of North America

SN - 1047-9422

IS - 2

ER -